Eli Lilly and Company's CEO Salary
- David A. Ricks Chair, President, and Chief Executive Officer at Eli Lilly and Company, received a total compensation of $29.24 M in 2024.
- Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology at Eli Lilly and Company, received a total compensation of $12.64 M in 2024.
- Anat Hakim Executive Vice President, General Counsel and Secretary at Eli Lilly and Company, received a total compensation of $7.48 M in 2024.
- Jake Van Naarden Executive Vice President and President, Loxo@Lilly at Eli Lilly and Company, received a total compensation of $5.77 M in 2024.
- Anat Ashkenazi 6 Executive Vice President and Chief Financial Officer at Eli Lilly and Company, received a total compensation of $4.96 M in 2024.
- Lucas Montarce Executive Vice President and Chief Financial Officer at Eli Lilly and Company, received a total compensation of $2.95 M in 2024.
- Gordon Brooks Interim CFO and Group Vice President - Controller and Corporate Strategy at Eli Lilly and Company, received a total compensation of $2.74 M in 2024.
Eli Lilly and Company's CEO salary and other executives compensation in 2024 was as follows:
Executive Compensation Summary Table
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| David A. Ricks Chair, President, and Chief Executive Officer | $29.24 M | $26.57 M | $21.40 M |
| Base Salary | $1.69 M | - | - |
| Incentive Plan Compensation | $5.71 M | $4.40 M | $2.70 M |
| All Other Compensation | $351.69 K | $263.07 K | $216.89 K |
| Stock Award | $19.75 M | $18.84 M | - |
| Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology | $12.64 M | $11.85 M | $8.46 M |
| Base Salary | $1.43 M | $1.33 M | $1.20 M |
| Incentive Plan Compensation | $3.22 M | $2.41 M | $1.44 M |
| All Other Compensation | $206.98 K | $79.85 K | $72.12 K |
| Stock Award | $7.50 M | $7.48 M | $5.75 M |
| Anat Hakim Executive Vice President, General Counsel and Secretary | $7.48 M | $7.01 M | $5.43 M |
| Base Salary | $1.00 M | $980.77 K | $875.96 K |
| Incentive Plan Compensation | $2.25 M | $1.78 M | $1.05 M |
| All Other Compensation | $66.83 K | $58.85 K | $52.56 K |
| Stock Award | $3.95 M | $3.95 M | $3.14 M |
| Jake Van Naarden Executive Vice President and President, Loxo@Lilly | $5.77 M | $4.89 M | $3.62 M |
| Base Salary | $890.39 K | $830.77 K | - |
| Incentive Plan Compensation | $2.00 M | $1.50 M | $882.69 K |
| All Other Compensation | $113.06 K | $49.85 K | $44.14 K |
| Stock Award | $2.70 M | $2.42 M | $1.93 M |
| Anat Ashkenazi 6 Executive Vice President and Chief Financial Officer | $4.96 M | $7.60 M | $5.26 M |
| Base Salary | $634.04 K | $1.03 M | $940.39 K |
| Incentive Plan Compensation | - | $1.87 M | $1.13 M |
| All Other Compensation | $38.04 K | $61.85 K | $56.42 K |
| Stock Award | $3.75 M | $3.69 M | $3.14 M |
| Lucas Montarce Executive Vice President and Chief Financial Officer | $2.95 M | - | - |
| Base Salary | $664.64 K | - | - |
| Incentive Plan Compensation | $1.11 M | - | - |
| All Other Compensation | $39.88 K | - | - |
| Stock Award | $1.07 M | - | - |
| Gordon Brooks Interim CFO and Group Vice President - Controller and Corporate Strategy | $2.74 M | - | - |
| Base Salary | $558.29 K | - | - |
| Incentive Plan Compensation | $667.66 K | - | - |
| All Other Compensation | $33.50 K | - | - |
| Stock Award | $1.30 M | - | - |
| Anat Ashkenazi Executive Vice President and Chief Financial Officer | - | $7.60 M | $5.26 M |
| Base Salary | - | - | $940.39 K |
| Incentive Plan Compensation | - | $1.87 M | $1.13 M |
| All Other Compensation | - | $61.85 K | $56.42 K |
| Stock Award | - | $3.69 M | $3.14 M |
| Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Medical Officer and President, Lilly Research Laboratories | - | - | $8.46 M |
| Base Salary | - | - | $1.20 M |
| Incentive Plan Compensation | - | - | $1.44 M |
| All Other Compensation | - | - | $72.12 K |
| Stock Award | - | - | $5.75 M |
| Anat Ashkenazi 5 Executive Vice President and Chief Financial Officer | - | - | $5.26 M |
| Base Salary | - | - | - |
| Incentive Plan Compensation | - | - | $1.13 M |
| All Other Compensation | - | - | $56.42 K |
| Stock Award | - | - | $3.14 M |
| Patrik Jonsson 5 Executive Vice President and President, Lilly Immunology, Lilly USA and Chief Customer Officer | - | - | $3.92 M |
| Base Salary | - | - | $740.39 K |
| Incentive Plan Compensation | - | - | $888.46 K |
| All Other Compensation | - | - | $44.42 K |
| Stock Award | - | - | $2.19 M |
